MARC Record from Library of Congress

LEADER: 03099cam a2200373 a 4500
001 2010003433
003 DLC
005 20141108080309.0
008 100203s2010 njua b 001 0 eng
010 $a 2010003433
016 7 $a101524032$2DNLM
020 $a9780470479964 (cloth)
020 $a0470479965 (cloth)
035 $a(OCoLC)ocn505422806
040 $aDNLM/DLC$cDLC$dYDX$dNLM$dBTCTA$dYDXCP$dCDX$dDLC
042 $apcc
050 00 $aRA762$b.S58 2010
060 10 $aQW 90$bS562 2010
082 00 $a610.28/4$222
100 1 $aShunmugaperumal, Tamilvanan.
245 10 $aBiofilm eradication and prevention :$ba pharmaceutical approach to medical device infections /$cTamilvanan Shunmugaperumal.
260 $aHoboken, N.J. :$bWiley,$cc2010.
300 $axiii, 423 p. :$bill. ;$c25 cm.
504 $aIncludes bibliographical references and index.
505 0 $a(Publisher-supplied data) Chapter 1. Introduction and Overview of Biofilm Chapter 2. Rationale for biofilm eradication from modern medical devices Chapter 3. Pathogenesis of device-related nosocomial infections Chapter 4. Biofilm resistance/tolerance to conventional antimicrobial agents Chapter 5. Analytical techniques useful to study biofilm Chapter 6. Biofilm-related infections in ophthalmology Chapter 7. Biofilm-related infections in oral cavity Chapter 8. Implications of biofilm formation in chronic wound and in cystic fibrosis Chapter 9. Strategies for prevention of device-related nosocomial infections Chapter 10. Liposomes as drug delivery carriers to biofilms Chapter 11. Polymer-based antimicrobial delivery carriers.
520 $a"Biofilm Eradication and Preventions presents the basics of biofilm formation on medical devices, diseases related to this formation, and approaches pharmaceutical researchers need to take to limit this problem. Split into three parts, the first deals with the development and characterization of biofilm on the surfaces of implanted or inserted medical devices. Questions as to why biofilms form over medical device surfaces and what triggers biofilm formation are addressed. In the second section, the author discusses biofilm-mediated chronic infections occurred in various organs (eyes, mouth, wounds) and pharmaceutical and drug delivery knowledge gained from research in these area. The third part explores pharmaceutical approaches like lipid-and polymer-based drug delivery carriers for eradicating biofilm on device-related infections. In addition, this section also explores the topic of novel small molecule (like iron and its complexes/metal chelators) and a quorum-sensing inhibitors to control medical biofilm formation"--Provided by publisher.
650 0 $aMedical instruments and apparatus$xMicrobiology.
650 0 $aBiofilms.
650 0 $aMedical instruments and apparatus$xSterilization.
650 12 $aBiofilms.
650 22 $aAnti-Infective Agents$xtherapeutic use.
650 22 $aDrug Carriers$xtherapeutic use.
650 22 $aProstheses and Implants$xmicrobiology.
650 22 $aProsthesis-Related Infections$xprevention & control.